Reboxetine
NRI antidepressant drug
Reboxetine
Reboxetine, sold under the brand name Edronax among others, is a selective norepinephrine reuptake inhibitor (sNRI) medication marketed as an antidepressant by Pfizer for use in the treatment of major depressive disorder, although it has also been used off-label for panic disorder and attention deficit hyperactivity disorder (ADHD). It is approved for use in many countries worldwide, but is not approved for use in the United States.
Read on Wikipedia · Image Jovan.gec, CC BY-SA 4.0
Open boosters, collect cards and trade them. Free to play.
Play for free